Aeris Therapeutics: Clinical Trials

18 trials sponsored by Aeris Therapeutics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 7 terminated, 2 withdrawn. 8 Phase 2, 6 Phase 1, 5 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 28Completed 5, Terminated 3
Phase 16Completed 5, Terminated 1
Phase 35Terminated 2, Withdrawn 2, Completed 1
Phase 41Terminated 1

Follow Aeris Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
AeriSeal Emphysematous Lung Sealant Syst - Emphysema, Chronic Obstructive Pulmonary Disease (COPD)
Phase 3WithdrawnAeris Therapeutics2013-09-012013-11-14
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
Treatment plus Optimal Medical Therapy, Optimal Medical Therapy - Pulmonary Emphysema
Phase 3TerminatedAeris Therapeutics3002012-06-012013-11-14
Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema
Emphysematous Lung Sealant - Pulmonary Emphysema
Phase 4TerminatedAeris Therapeutics1002012-02-012013-11-14
Post Market Registry Study of the AeriSeal System
Pulmonary Emphysema
TerminatedAeris Therapeutics252012-02-012013-11-14
A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
AeriSeal System - Pulmonary Emphysema, Chronic Obstructive Pulmonary Disease(COPD)
Phase 2 / Phase 3TerminatedAeris Therapeutics182011-03-012013-11-14
A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema
Chronic Pulmonary Obstructive Disease, Emphysema
TerminatedAeris Therapeutics542011-01-012013-11-14
AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema
AeriSeal System - Pulmonary Emphysema, COPD
Phase 2 / Phase 3CompletedAeris Therapeutics202010-08-012011-10-21
AeriSeal System for Lung Volume Reduction
AeriSeal System - Emphysema, Chronic Obstructive Pulmonary Disease (COPD)
Phase 1 / Phase 2CompletedAeris Therapeutics552009-11-012013-06-26
A Dose Ranging Study of the Aeris Polymeric Lung Volume Reduction (PLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema
Polymeric Lung Volume Reduction System (PLVR) - Advanced Emphysema
Phase 1CompletedAeris Therapeutics252008-12-012011-10-21
Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema
BLVR - Advanced Upper Lobe Predominant Emphysema
Phase 3WithdrawnAeris Therapeutics2252008-12-012010-01-18
Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study
Biologic Lung Volume Reduction - Homogeneous Emphysema
Phase 2CompletedAeris Therapeutics332008-02-012011-10-24
US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
Biologic Lung Volume Reduction (BLVR) - 20 mL Hydrogel - Pulmonary Emphysema, Chronic Obstructive Pulmonary Disease
Phase 2CompletedAeris Therapeutics222007-08-012011-10-24
Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
Biologic Lung Volume Reduction (BLVR) - 10 mL Hydrogel - Pulmonary Emphysema, Chronic Obstructive Pulmonary Disease
Phase 1CompletedAeris Therapeutics162007-05-012010-01-18
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
BLVR Treatment - Pulmonary Emphysema
Phase 2CompletedAeris Therapeutics202007-02-012011-10-24
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
BLVR System - Pulmonary Emphysema
Phase 1CompletedAeris Therapeutics62006-06-012008-03-06
Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
BLVR Hydrogel - Pulmonary Emphysema
Phase 2TerminatedAeris Therapeutics52005-05-012010-01-18
US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation
BLVR - Pulmonary Emphysema
Phase 1CompletedAeris Therapeutics62005-04-012008-03-06
Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
BLVR Hydrogel - Pulmonary Emphysema
Phase 1 / Phase 2TerminatedAeris Therapeutics42005-01-012008-03-06

Conditions studied

Emphysema (17)  ·  Pulmonary Disease, Chronic Obstructive (17)  ·  Pulmonary Emphysema (13)  ·  Lung Diseases (7)  ·  Respiratory Aspiration (5)  ·  Respiratory Tract Diseases (5)  ·  Pathologic Processes (3)

Interventions

Hydrogels (2)  ·  Pneumonectomy (1)  ·  Therapeutics (1)

Countries

Israel (9)  ·  United States (6)  ·  Germany (5)  ·  France (3)  ·  Austria (2)  ·  Netherlands (2)  ·  Greece (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Gerard Criner, MD (3)  ·  Mark Gotfried, MD (3)  ·  Charlie Strange, MD (2)  ·  Geoffrey McLennan, MD (2)  ·  Janine McDermott, MS CCRP (2)  ·  Mark Dransfield, MD (2)  ·  Mark Krasna, MD (2)  ·  Sanjiv Tewari, MD (2)  ·  Thomas Gildea, MD (2)  ·  William Leeds, DO (2)  ·  Felix Herth, Prof. Dr med (1)  ·  Issahar Ben-Dov, MD (1)  ·  John J. Reilly, MD (1)  ·  Manfred Wagner, Dr med (1)  ·  Martin Hetzel, Dr med (1)

Results publications

PMID 22374920, PMID 19179484, PMID 25837041, PMID 33590989